• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, November 11, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

MDFA responds after NSW health chief says eye checks can be deferred  

by Myles Hume
July 23, 2021
in Local, News
Reading Time: 3 mins read
A A
Sydney lockdown eye appointments

Sydney recorded 124 cases on 22 July, with lockdowns expected to be extended.

Share on FacebookShare on Twitter

NSW chief health officer Dr Kerry Chant’s use of eye appointments as an example of activities that can be deferred during the lockdown has prompted the Macular Disease Foundation Australia (MDFA) to warn patients they should seek advice from an eyecare professional first.

The organisation sought to clarify the matter after Chant said eye checks were something that could be put off during lockdown, as long as people weren’t experiencing “pain or other issues”, at the daily COVID-19 media conference on Monday 19 July.

It comes as MDFA notes alarming anecdotal evidence that patients are once again cancelling anti-VEGF injection appointments during lockdowns, with more than half of those cancelling in a high volume Sydney clinic this week.

MDFA warned patients that while eye pain was a sign of a medical emergency, it was not the only indicator of whether they needed to seek urgent medical help for an eye health emergency.

A/Prof Alex Hunyor.

Associate Professor Alex Hunyor, chair of MDFA’s Medical Committee, said Australia was facing an increase in the number of people who could unnecessarily lose their sight due to treatment cancellations caused by fear and confusion around COVID-19 and the Delta variant.

“Any sudden changes in your vision – even without pain – could be an eye emergency. Deferring an eye appointment in those circumstances could cause irreversible vision loss,” said.

“Many urgent, sight-threatening conditions – including wet age-related macular degeneration (AMD), diabetic macular oedema (DMO) and retinal detachment – aren’t painful.

“Similarly, if you are already receiving essential eye injections or laser treatment for wet AMD, DMO or treatment for any other eye condition, I strongly urge you to keep your scheduled appointment.”

MDFA CEO Dee Hopkins said at the beginning of the COVID-19 pandemic in 2020, there was “a worrying increase” in the number of cancelled essential appointments, particularly for intravitreal injections.

“MDFA rolled out a national campaign, featuring MDFA’s Patron Ita Buttrose AC OBE, to counter this trend last year. The anecdotal evidence is that people are once again cancelling sight-saving appointments as several states battle the virulent Delta strain,” she said.

Dee Hopkins.

“At one busy Sydney clinic on Monday, only 23 of 43 scheduled patients attended for their eye injections. If this is a barometer of what is happening more broadly, the implications are quite concerning.”

She said Chant was correct in saying that some eye checks – such as for glasses – could be safely deferred. However, if people experiences sudden changes or loss of vision, she urged them to immediately call their optometrist for urgent advice.

“Specialist eye treatments need to continue as scheduled as they are considered to be medically essential,” Hopkins said.

“If you require injections for wet AMD or DMO or other macular conditions, it is essential that you attend your specialist appointment or discuss your treatment options with your ophthalmologist.”

More reading

Lockdown aged care policies proving a major barrier for patients

Annual out-of-pocket eye injection costs to double to $3,900 under rebate cut – modelling

Awareness of diabetic eye diseases lacking – MDFA poll

Tags: AMDcancelleddeferreddiabetic macular oedemaDMOeye appointmentseye injectionsMacular Disease Foundation AustraliaMDFANSW chief health officer Dr Kerry Chantwet age-related macular degeneration

Related Posts

Workforce data shows orthoptists independently screen, triage, and monitor eye conditions. Image: Viacheslav Yakobchuk/stock.adobe.com.

Capturing the orthoptic workforce in 2025

by Amanda French
November 11, 2025

Orthoptics Australia’s 2025 Workforce Survey reveals critical insights into a growing, diversifying profession – addressing data gaps vital for future...

The Proveo 8x 3D digital microscope delivers comfortable visualisation for surgeons and effective learning for trainees. Images: Leica Microsystems.

Seeing beyond the lens: Leica Microsystems to reveal next-gen microscope at RANZCO 2025

by Staff Writer
November 11, 2025

Leica Microsystems is set to unveil its new digital microscope and surgical visualisation headset at RANZCO 2025, marking a leap...

Restaurateur, broadcaster and author Dame Prue Leith is known for her rainbow wardrobe and statement jewellery. Image: Loredana Sangiuliano/shutterstock.com.

A burst of British colour – new collection coming to Australia

by Staff Writer
November 11, 2025

From the set of The Great British Bake Off to Australian optical practices, Dame Prue Leith’s signature love of colour...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited